Gambia Quickly Recalls Cough Syrups Made In India After 66 Child Fatalities Were Reported
The Gambia has begun a door-to-door campaign to demand the urgent withdrawal of cough and cold medications made in India, which are to blame for the deaths of more than 60 children in the West African nation. The ministry of health has sent hundreds of young people on a house-to-house effort to collect the questionable syrups while collaborating with the Gambia Red Cross Society.
The children’s deaths from acute renal injury were confirmed by Mustapha Bittaye, the Gambia’s director of health, according to the Associated Press.
In response to the fatalities, the World Health Organization issued a medical alert, classifying four medications produced by the Haryana-based Maiden Pharmaceuticals Limited as substandard medical products: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.
The four goods were found in The Gambia, according to the UN health agency alert, but may have been distributed, through informal markets, to other countries or regions.
The Medical Research Council of Gambia has also raised a warning.
The medicine has been shown to have a sizable amount of poison that permanently harms the kidneys.
According to Reuters, a top official at Maiden Pharmaceuticals stated that the company is attempting to get information from its buyer in the Gambia on the deaths of infants.
News Mania Desk
